Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

23andMe discovers surprising genetic connections between breast size and breast cancer

04.07.2012
7 novel genetic associations identified for breast size, including 3 already linked to breast cancer

Using data from its unique online research platform, 23andMe, a leading personal genetics company, has identified seven single-nucleotide polymorphisms (SNPs) significantly associated with breast size, including three SNPs also correlated with breast cancer in a genome-wide association study (GWAS) now published online in BMC Medical Genetics. These findings make the first concrete genetic link between breast size and breast cancer risks.

These findings were made analyzing data from 16,175 female 23andMe customers of European ancestry, comparing their answers to survey questions including bra cup size and bra band size to genetic data at millions of SNPs. The analysis controlled for age, genetic ancestry, breast surgeries, breast feeding status and pregnancy history.

"The 23andMe research platform is a robust source of new genetic discoveries and this study demonstrates that important scientific insights can come from the most unlikely places," stated 23andMe CEO and co-founder Anne Wojcicki. "Nearly 90 percent of our more than 150,000 customers participate in our online research allowing 23andMe to make discoveries faster and more cost effectively than traditional research models," added Wojcicki.

While some factors of breast morphology, such as density, are known to be directly implicated in breast cancer, the relationship between breast size and cancer is less clear. While breast size is heritable, this study is the first to identify genetic variants linked to differences in breast size.

"The findings in this study show that some of the same biological pathways underlie both normal breast growth and breast cancer," explained lead author Nicholas Eriksson, Ph.D. "Some studies have found that larger breast size as a young woman is associated with a slightly higher risk for breast cancer. The genetic factors we found support this concept that breast size and breast cancer are related."

The novel loci associated with breast size are rs7816345 near ZNF703, rs4849887 and rs17625845 flanking INHBB, rs12173570 near ESR1, rs7089814 in ZNF365, rs12371778 near PTHLH, and rs62314947 near AREG. Two of these SNPs are strongly correlated with SNPs associated with breast cancer (those near ESR1 and PTHLH), and a third (ZNF365) is near another breast cancer SNP. The other three loci (ZNF703, INHBB, and AREG) have strong links to estrogen regulation and breast development.

"These results provide insight into the genetic factors underlying normal breast development and show that some of these factors are shared with breast cancer," concluded Eriksson. "While these results do not directly support the known epidemiological relationships between breast size and cancer, this study contributes to a better understanding of the subtle interactions between breast morphology and breast cancer risk."

These breast size/breast cancer results continue to show the power of 23andMe's methodology in combining self-reported data on a broad range of phenotypes gathered via web-based questionnaires with genotypic data derived from self-collected saliva samples.

23andMe had previously published its first proof-of-concept results in the journal PLoS Genetics in June 2010, which reported novel associations for unusual traits such as asparagus anosmia and photic sneeze reflex and replicated associations for other common genetic traits, published the discovery of two novel genetic associations for Parkinson's disease in PLoS Genetics, and presented a major replication study of over 180 genetic associations in the journal PLoS ONE. In April of 2012, 23andMe published a study in the journal PLoS ONE which reported five novel significant genetic associations for hypothyroidism in the largest known genome-wide association study of hypothyroidism conducted to date. Most recently 23andMe published its finding of novel associations found for male pattern baldness, some of which are also linked to Parkinson's disease and prostate cancer, in PLoS Genetics.

23andMe customers see the results incorporated into the reports provided in their online accounts over time.

23andMe continues to be active in the investigation of breast cancer as it collaborates with Genentech in their InVite Study to understand how genes influence response to treatment for metastatic breast cancer. Anyone who has had metastatic breast cancer may be eligible to participate and can learn more at https://www.23andme.com/invite-study/ or by emailing invite-study@23andme.com.

About 23andMe

23andMe, Inc. is a leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service® enables individuals to gain deeper insights into their ancestry and inherited traits. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research. 23andMe, Inc., was founded in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science. More information is available at www.23andme.com.

Media Contacts:

Rubenstein Communications
1345 Ave of the Americas
New York, NY 10105
Contacts:
Jane Rubinstein, 212-843-8287, jrubinstein@rubenstein.com
Alison Hendrie, 212-843-8029, ahendrie@rubenstein.com

Jane E. Rubinstein | EurekAlert!
Further information:
http://www.23andme.com

More articles from Studies and Analyses:

nachricht Drone vs. truck deliveries: Which create less carbon pollution?
31.05.2017 | University of Washington

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>